Revolution Medicines
RVMD
RVMD
278 hedge funds and large institutions have $8.45B invested in Revolution Medicines in 2024 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 123 increasing their positions, 56 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
10% more capital invested
Capital invested by funds: $7.66B → $8.45B (+$785M)
4.75% more ownership
Funds ownership: 101.12% → 105.87% (+4.8%)
16% less call options, than puts
Call options by funds: $42.3M | Put options by funds: $50.2M
Holders
278
Holding in Top 10
23
Calls
$42.3M
Puts
$50.2M
Top Buyers
| 1 | +$146M | |
| 2 | +$95.6M | |
| 3 | +$84.5M | |
| 4 |
NI
Nextech Invest
Zurich,
Switzerland
|
+$57.1M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$54.2M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$22M | |
| 3 | -$21.2M | |
| 4 |
CC
Casdin Capital
New York
|
-$18.2M |
| 5 |
FAM
Fred Alger Management
New York
|
-$17.2M |